Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration (DEA) Executive Assistant for Misuse of Position, Prohibited Association with a Former DEA Confidential Source, and Soliciting and Accepting Gifts from the Former DEA Confidential Source
- NARA ID
- investigative-summary-findings-misconduct-drug-enforcement-administration-dea-executive
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Investigation
- Released
- 2024-08-01
- Slug
- doj-oig-investigative-summary-findings-misconduct-drug-enforcement-administration-dea-executive
- Indexed
- 2026-04-27 05:01:02
More from DOJ OIG — Drug Enforcement Administration
- Audit of the Drug Enforcement Administration’s Laboratory Information Management System Support Contracts
- Management Advisory Memorandum – Notification of Concerns Relating to the DEA’s Untimely Reporting of Potential Human Rights Violations by Foreign Law Enforcement
- Review of the Drug Enforcement Administration's Accounting of Drug Control Funding Fiscal Year 2024
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration Special Agent in Charge for Installing and Remotely Monitoring an Unauthorized Personally-Owned Camera in the DEA Office
- Audit of the Drug Enforcement Administration's Income-Generating, Undercover Operations
- Memorandum for the Deputy Attorney General: Recommendation for the Drug Enforcement Administration to Review whether its Field Offices are Engaging in Unlawful Fundraising on Behalf of the Drug Enforcement Administration Survivors Benefit Fund
Browse all 60 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.